Back to VRTX
Reynders McVeigh Capital Management, LLC → VRTX
Reynders McVeigh Capital Management, LLC VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
5
Latest value
$30M
Q3 2026
Peak value
$30M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $21.7M |
| Q4 2025 | $24.4M |
| Q1 2026 | $24.4M |
| Q2 2026 | $27.1M |
| Q3 2026 | $30M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $30M | 57.4K | — | — |
| Q2 2026 | $27.1M | 54.5K | — | — |
| Q1 2026 | $24.4M | 54.7K | — | — |
| Q4 2025 | $24.4M | 53.9K | — | — |
| Q3 2025 | $21.7M | 55.4K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B